<DOC>
	<DOCNO>NCT00425555</DOCNO>
	<brief_summary>This study evaluate safety efficacy LBH489B adult patient refractory Cutaneous T-Cell Lymphoma .</brief_summary>
	<brief_title>Study Oral LBH589 Adult Patients With Refractory Cutaneous T-Cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Panobinostat</mesh_term>
	<mesh_term>Bexarotene</mesh_term>
	<criteria>Inclusion criterion : 1 . Written inform consent obtain prior screen procedure 2 . Age ≥ 18 year old 3 . Patients biopsyconfirmed stage IBIVA mycosis fungoides Sézary syndrome . Patients SS bone marrow involvement also eligible . 4 . Patients must receive least two prior treatment regimen least one systemic therapy regimen . Systemic regimen include oral bexarotene , PUVA , photophoresis , chemotherapy methotrexate , interferon . Topical steroid alone consider treatment regimen . 5 . Patients must disease progression follow recent treatment regimen inadequate response recent treatment regimen . 6 . Patients accrue one two group : Patients previously treat oral bexarotene patient prior oral bexarotene treatment . Exclusion criterion : 1 . Prior treatment HDAC inhibitor . 2 . Patients visceral disease include CNS involvement ( i.e . stage IVB CTCL ) . Note ; Patients SS bone marrow involvement eligible . 3 . Impaired cardiac function 4 . Concomitant use drug risk cause torsades de pointes 5 . Patients receive chemotherapy investigational drug undergone major surgery &lt; 4 week prior start study drug recover side effect therapy 6 . Less 3 month since prior electron beam therapy 7 . Female patient pregnant breast feeding , patient reproductive potential use effective method birth control , male patient whose sexual partner woman childbearing potential use effective birth control Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Cutaneous T-Cell Lymphoma , adult</keyword>
	<keyword>Mycosis Fungoides</keyword>
	<keyword>Sézary Syndrome</keyword>
	<keyword>CTCL</keyword>
</DOC>